Rhenium-188 is one of the most readily available generator derived and useful
radionuclides for therapy emitting β-particles (2.12 MeV, 71.1% and 1.965 MeV, 25.6%) and …

Targeted radionuclide therapy (TRNT) is an ever-expanding field of nuclear medicine that
provides a personalised approach to cancer treatment while limiting toxicity to normal …

PURPOSE: Protection of bone marrow against radiotoxicity during radioimmunotherapy and
in some cases external beam radiation therapy such as hemi-body irradiation would permit …

Abstract Development of reporter genes for multimodality molecular imaging is highly
important. In contrast to the conventional strategies which have focused on fusing several …

Abstract Lutetium-177 (177 Lu) radiolabeled ultrasmall (~ 6 nm dia.) fluorescent core-shell
silica nanoparticles (Cornell prime dots or C′ dots) were developed for improving efficacy …

Melanin is major cause of dark skin, which is regarded as social status in eastern Asia. As a
result, researchers in cosmetic industries are developing skin whitening agents. Melanin can …

Cutaneous melanoma arises from proliferating melanocytes, cells specialized in the
production of melanin. This property means melanin can be considered as a target for …

Melanocortin-1 receptor (MC1-R) and melanin are two attractive melanoma-specific targets
for peptide-targeted radionuclide therapy for melanoma. Radiolabeled peptides targeting …

Melanin is one of the representative biomarkers of malignant melanoma and a potential
target for diagnosis and therapy. With advancements in chemistry and radiolabeling …

Melanoma represents the most aggressive form of skin cancer, and its incidence continues
to rise worldwide. 18 F–FDG PET imaging has transformed diagnostic nuclear medicine and …